<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Center for Innovation &amp; Free Enterprise</title><description>Clearing the path for innovation</description><link>https://cifeusa.org/</link><item><title>Protecting American Innovation: Why Intellectual Property Matters More Than Ever</title><link>https://cifeusa.org/blog/protecting-american-innovation-why-intellectual-property-matters-more-than-ever/</link><guid isPermaLink="true">https://cifeusa.org/blog/protecting-american-innovation-why-intellectual-property-matters-more-than-ever/</guid><description>October is National Intellectual Property Month, an opportunity to recognize the inventors, entrepreneurs, researchers, and creators whose ingenuity powers the American economy. It is also an important reminder that the United States’ position as a global leader in innovation is no accident. It is the result of a longstanding commitment to protecting intellectual property (IP) […]</description><pubDate>Wed, 21 Oct 2026 17:23:46 GMT</pubDate></item><item><title>CIFE Launches Education Campaign for World IP Day</title><link>https://cifeusa.org/blog/cife-launches-education-campaign-for-world-ip-day/</link><guid isPermaLink="true">https://cifeusa.org/blog/cife-launches-education-campaign-for-world-ip-day/</guid><description>From innovation to employment, IP’s role in job growth is vital. For World IP Day, the Center for Innovation and Free Enterprise highlights key intellectual property facts and figures in all 50 states utilizing the information reported in the U.S. Chamber Report .</description><pubDate>Tue, 22 Sep 2026 13:26:29 GMT</pubDate></item><item><title>The Center for Innovation and Free Enterprise (CIFE) supports the Office of the United States Trade Representative’s investigation into Germany’s persistent underpayment for innovative pharmaceutical products</title><link>https://cifeusa.org/blog/the-center-for-innovation-and-free-enterprise-cife-supports-the-office-of-the-united-states-trade-representatives-investigation-into-germanys-persistent-underpayment-for-innovative/</link><guid isPermaLink="true">https://cifeusa.org/blog/the-center-for-innovation-and-free-enterprise-cife-supports-the-office-of-the-united-states-trade-representatives-investigation-into-germanys-persistent-underpayment-for-innovative/</guid><description>The Center for Innovation and Free Enterprise (CIFE) supports the Office of the United States Trade Representative’s investigation into Germany’s persistent underpayment for innovative pharmaceutical products. CIFE commends Ambassador Greer and the Administration for using Section 301 of the Trade Act of 1974 to examine whether Germany’s pharmaceutical pricing practices are unreasonable or discriminatory and […]</description><pubDate>Mon, 10 Aug 2026 14:18:55 GMT</pubDate></item><item><title>The Center for Innovation and Free Enterprise supports policies that promote both innovation and patient access</title><link>https://cifeusa.org/blog/the-center-for-innovation-and-free-enterprise-supports-policies-that-promote-both-innovation-and-patient-access/</link><guid isPermaLink="true">https://cifeusa.org/blog/the-center-for-innovation-and-free-enterprise-supports-policies-that-promote-both-innovation-and-patient-access/</guid><description>As the Senate HELP Committee prepares to consider S.2658, S.1954, and S.3014, the Center for Innovation and Free Enterprise respectfully urges lawmakers to consider the gravity these proposals will have on medical innovation. While framed as efforts to increase competition and lower costs, these bills would weaken intellectual property protections that are essential to the […]</description><pubDate>Thu, 18 Jun 2026 12:14:25 GMT</pubDate></item><item><title>The Center for Innovation and Free Enterprise encourages Congress to take a comprehensive approach to hospital reform</title><link>https://cifeusa.org/blog/the-center-for-innovation-and-free-enterprise-encourages-congress-to-take-a-comprehensive-approach-to-hospital-reform/</link><guid isPermaLink="true">https://cifeusa.org/blog/the-center-for-innovation-and-free-enterprise-encourages-congress-to-take-a-comprehensive-approach-to-hospital-reform/</guid><description>Today the House Energy &amp;amp; Commerce Committee held a hearing examining the drivers of rising health care costs in the United States. As policymakers consider solutions to improve affordability and access, it is critical to address the growing role that hospital systems and misaligned federal policies play in driving up costs for patients and employers. […]</description><pubDate>Wed, 18 Mar 2026 15:32:01 GMT</pubDate></item><item><title>AI Policy, Energy, and the 50-State Patchwork</title><link>https://cifeusa.org/blog/ai-policy-energy-and-the-50-state-patchwork/</link><guid isPermaLink="true">https://cifeusa.org/blog/ai-policy-energy-and-the-50-state-patchwork/</guid><description>AI Policy, Energy, and the 50-State Patchwork: CIFE’s Takeaways from the U.S. Chamber Technology Leadership Summit &amp;nbsp; CIFE attended the U.S. Chamber’s 2026 Technology Leadership Summit in Washington, with a room full of executives, innovators, and policy advocates working to ensure America remains a global leader in technology and innovation. The theme was “Deploy and […]</description><pubDate>Thu, 12 Mar 2026 16:49:17 GMT</pubDate></item><item><title>Onorio Named Chief Executive Officer</title><link>https://cifeusa.org/blog/onorio-named-chief-executive-officer/</link><guid isPermaLink="true">https://cifeusa.org/blog/onorio-named-chief-executive-officer/</guid><description>Americans for a Balanced Budget and the Center for Innovation and Free Enterprise Name Laurie Onorio Chief Executive Officer FOR IMMEDIATE RELEASE March 10, 2026 Contact: Ginevra Joyce-Myers 202-506-5320 WASHINGTON, DC – Americans for a Balanced Budget (ABB) and the Center for Innovation and Free Enterprise (CIFE) today named Laurie Onorio as Chief Executive Officer. […]</description><pubDate>Thu, 05 Mar 2026 09:33:06 GMT</pubDate></item><item><title>If Congress is serious about lowering health care costs in 2026, insurance reform cannot remain optional.</title><link>https://cifeusa.org/blog/if-congress-is-serious-about-lowering-health-care-costs-in-2026-insurance-reform-cannot-remain-optional/</link><guid isPermaLink="true">https://cifeusa.org/blog/if-congress-is-serious-about-lowering-health-care-costs-in-2026-insurance-reform-cannot-remain-optional/</guid><description>As Washington turns its attention to health care costs once again, Congress has an important opportunity and obligation to confront a reality millions of Americans already know too well – insurance is getting more expensive while delivering less value. Tens of millions of Americans face higher premiums, shrinking provider networks, longer wait times for care, […]</description><pubDate>Wed, 21 Jan 2026 20:53:30 GMT</pubDate></item><item><title>The Center for Innovation and Free Enterprise encourages Congress to continue to support the U.S. patent system</title><link>https://cifeusa.org/blog/the-center-for-innovation-and-free-enterprise-encourages-congress-to-continue-to-support-the-u-s-patent-system/</link><guid isPermaLink="true">https://cifeusa.org/blog/the-center-for-innovation-and-free-enterprise-encourages-congress-to-continue-to-support-the-u-s-patent-system/</guid><description>The Center for Innovation and Free Enterprise encourages Congress to continue to support the U.S. patent system. This means opposing unnecessary legislation as part of an end-of-year package. The Senate Committee on Health, Education, Labor and Pensions (HELP) is planning to hold a markup that will include two pieces of legislation that fall under unnecessary […]</description><pubDate>Sat, 31 Aug 2024 17:10:42 GMT</pubDate></item><item><title>CIFE encourages the USPTO to end the strategic abuse of the PTAB</title><link>https://cifeusa.org/blog/cife-submits-a-comment-responding-to-nprm/</link><guid isPermaLink="true">https://cifeusa.org/blog/cife-submits-a-comment-responding-to-nprm/</guid><description>June 10, 2024 CIFE encourages the USPTO to end the strategic abuse of the PTAB The Center for Innovation and Free Enterprise (CIFE) would like to respond to the Request for Comments Regarding the Notice of Proposed Rulemaking (NPRM) on “Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules […]</description><pubDate>Thu, 27 Jun 2024 00:47:47 GMT</pubDate></item></channel></rss>